Literature DB >> 17502353

Phosphorylation of Bcl10 negatively regulates T-cell receptor-mediated NF-kappaB activation.

Hu Zeng1, Lie Di, Guoping Fu, Yuhong Chen, Xiang Gao, Langlai Xu, Xin Lin, Renren Wen.   

Abstract

Bcl10 (B-cell lymphoma 10) is an adaptor protein comprised of an N-terminal caspase recruitment domain and a C-terminal serine/threonine-rich domain. Bcl10 plays a critical role in antigen receptor-mediated NF-kappaB activation and lymphocyte development and functions. Our current study has discovered that T-cell activation induced monophosphorylation and biphosphorylation of Bcl10 and has identified S138 within Bcl10 as one of the T-cell receptor-induced phosphorylation sites. Alteration of S138 to an alanine residue impaired T-cell activation-induced ubiquitination and subsequent degradation of Bcl10, ultimately resulting in prolongation of TCR-mediated NF-kappaB activation and enhancement of interleukin-2 production. Taken together, our findings demonstrate that phosphorylation of Bcl10 at S138 down-regulates Bcl10 protein levels and thus negatively regulates T-cell receptor-mediated NF-kappaB activation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17502353      PMCID: PMC1951946          DOI: 10.1128/MCB.01645-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  64 in total

Review 1.  CARMA1, BCL-10 and MALT1 in lymphocyte development and activation.

Authors:  Margot Thome
Journal:  Nat Rev Immunol       Date:  2004-05       Impact factor: 53.106

2.  Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins.

Authors:  Vigo Heissmeyer; Fernando Macián; Sin-Hyeog Im; Rajat Varma; Stefan Feske; K Venuprasad; Hua Gu; Yun-Cai Liu; Michael L Dustin; Anjana Rao
Journal:  Nat Immunol       Date:  2004-02-15       Impact factor: 25.606

3.  T cell activation determined by T cell receptor number and tunable thresholds.

Authors:  A Viola; A Lanzavecchia
Journal:  Science       Date:  1996-07-05       Impact factor: 47.728

Review 4.  The NF-kappa B and I kappa B proteins: new discoveries and insights.

Authors:  A S Baldwin
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

5.  Proteasome-dependent down-regulation of activated Stat5A in the nucleus.

Authors:  Yuhong Chen; Xuezhi Dai; Arthur L Haas; Renren Wen; Demin Wang
Journal:  Blood       Date:  2006-03-28       Impact factor: 22.113

6.  Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction.

Authors:  G Schönrich; U Kalinke; F Momburg; M Malissen; A M Schmitt-Verhulst; B Malissen; G J Hämmerling; B Arnold
Journal:  Cell       Date:  1991-04-19       Impact factor: 41.582

7.  Activation-induced ubiquitination of the T cell antigen receptor.

Authors:  C Cenciarelli; D Hou; K C Hsu; B L Rellahan; D L Wiest; H T Smith; V A Fried; A M Weissman
Journal:  Science       Date:  1992-08-07       Impact factor: 47.728

8.  An important role of phospholipase Cgamma1 in pre-B-cell development and allelic exclusion.

Authors:  Renren Wen; Yuhong Chen; James Schuman; Guoping Fu; Shoua Yang; Weiguo Zhang; Debra K Newman; Demin Wang
Journal:  EMBO J       Date:  2004-09-16       Impact factor: 11.598

9.  Antibody-induced modulation of the CD3/T cell receptor complex causes T cell refractoriness by inhibiting the early metabolic steps involved in T cell activation.

Authors:  G Pantaleo; D Olive; A Poggi; T Pozzan; L Moretta; A Moretta
Journal:  J Exp Med       Date:  1987-08-01       Impact factor: 14.307

10.  Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus.

Authors:  R G Hawley; A Z Fong; B F Burns; T S Hawley
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

View more
  24 in total

Review 1.  NF-κB signaling pathways regulated by CARMA family of scaffold proteins.

Authors:  Marzenna Blonska; Xin Lin
Journal:  Cell Res       Date:  2010-12-28       Impact factor: 25.617

2.  BCL10 is recruited to sites of DNA damage to facilitate DNA double-strand break repair.

Authors:  Ismail Hassan Ismail; Ashley Dronyk; Xiuying Hu; Michael J Hendzel; Andrew R Shaw
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

3.  Identification of novel members reveals the structural and functional divergence of lepidopteran-specific Lipoprotein_11 family.

Authors:  Yan Zhang; Zhaoming Dong; Shiping Liu; Qiang Yang; Ping Zhao; Qingyou Xia
Journal:  Funct Integr Genomics       Date:  2012-04-26       Impact factor: 3.410

4.  MAGUK-controlled ubiquitination of CARMA1 modulates lymphocyte NF-kappaB activity.

Authors:  Miguel E Moreno-García; Karen Sommer; Hisaaki Shinohara; Ashok D Bandaranayake; Tomohiro Kurosaki; David J Rawlings
Journal:  Mol Cell Biol       Date:  2009-12-14       Impact factor: 4.272

Review 5.  The CBM signalosome: potential therapeutic target for aggressive lymphoma?

Authors:  Chenghua Yang; Liron David; Qi Qiao; Ermelinda Damko; Hao Wu
Journal:  Cytokine Growth Factor Rev       Date:  2013-12-24       Impact factor: 7.638

Review 6.  Regulation of NF-κB by the CARD proteins.

Authors:  Changying Jiang; Xin Lin
Journal:  Immunol Rev       Date:  2012-03       Impact factor: 12.988

7.  A quantitative signaling screen identifies CARD11 mutations in the CARD and LATCH domains that induce Bcl10 ubiquitination and human lymphoma cell survival.

Authors:  Waipan Chan; Thomas B Schaffer; Joel L Pomerantz
Journal:  Mol Cell Biol       Date:  2012-11-12       Impact factor: 4.272

8.  Negative Regulation of CARD11 Signaling and Lymphoma Cell Survival by the E3 Ubiquitin Ligase RNF181.

Authors:  Sarah M Pedersen; Waipan Chan; Rakhi P Jattani; deMauri S Mackie; Joel L Pomerantz
Journal:  Mol Cell Biol       Date:  2015-12-28       Impact factor: 4.272

Review 9.  CARMA1-mediated NF-kappaB and JNK activation in lymphocytes.

Authors:  Marzenna Blonska; Xin Lin
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

10.  COP9 signalosome controls the Carma1-Bcl10-Malt1 complex upon T-cell stimulation.

Authors:  Verena Welteke; Andrea Eitelhuber; Michael Düwel; Katrin Schweitzer; Michael Naumann; Daniel Krappmann
Journal:  EMBO Rep       Date:  2009-05-15       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.